# Combination of TURP and Standard Systemic Therapy for MPCa

> **NCT06655259** · PHASE2 · RECRUITING · sponsor: **Fudan University** · enrollment: 200 (estimated)

## Conditions studied

- Metastatic Prostate Cancer

## Interventions

- **PROCEDURE:** TURP
- **DRUG:** Standard Medical Therapy

## Key facts

- **NCT ID:** NCT06655259
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-21
- **Primary completion:** 2026-09
- **Final completion:** 2026-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06655259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06655259, "Combination of TURP and Standard Systemic Therapy for MPCa". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06655259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*